CJC-1295/Ipamorelin + Wolverine Blend: High compatibility, recommended
For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection
This data is compelling, but remember, plenty of weight loss medications are available now that people do well on, whether thats semaglutide by itself, tirzepatide, or other options (more on that below)
DSIP has become increasingly popular among peptide researchers interested in restorative biological signaling and neurophysiological pathway investigations
BPC-157 primarily engages angiogenic signaling (VEGF pathway modulation) and nitric oxide system regulation, addressing vascularization limits in tendon healing